Get startedLog in
    Picture of Zealand Pharma A/S logo

    ZEAL — Zealand Pharma A/S News Story

    0.000.00%
    dk flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMid CapNeutral
    All News

    Brief: Zealand Pharma Keeps Financial Guidance For 2026 Unchanged

    Picture of Zealand Pharma A/S logoZealand Pharma A/S
    13/08/2026 06:10
    BRIEF-Zealand Pharma Keeps Financial Guidance For 2026 Unchanged
    Aug 13 (Reuters) - Zealand Pharma A/S ZELA.CO:
    • ZEALAND PHARMA H1 OPERATING EXPENSES DKK -1,204 MILLION
    • ZEALAND PHARMA H1 REVENUE DKK 4,525 MILLION
    • ZEALAND PHARMA H1 OPERATING RESULT DKK 3,321 MILLION
    • FINANCIAL GUIDANCE FOR COLLABORATION REVENUE AND OPERATING EXPENSES FOR 2026 IS UNCHANGED
    Source text: ID:nGNEbhF7pw
    Further company coverage: ZELA.CO

     (Gdansk Newsroom)
     ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on Zealand Pharma A/S

    See all news